Autoliv Downgraded to Sell and 4 Downgraded Shares to Notice

October 05, 2012

Wall St. Watchdog reveals information about companies for which stock analysts downgraded the shares on October 5th.

Endo Pharm (NASDAQ:ENDP): RBC Capital Mkts downgraded its rating on this company from Outperform to Sector Perform and changed its price target from $36 to $35.

Gardner Denver (NYSE:GDI): KeyBanc Capital Mkts downgraded its rating on this company from Buy to Hold.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Hewlett-Packard (NYSE:HPQ): Argus downgraded its rating on this company from Buy to Hold.

Biogen Idec (NASDAQ:BIIB): Oppenheimer downgraded its rating on this company from Outperform to Perform.

Autoliv (NYSE:ALV): UBS downgraded its rating on this company from Neutral to Sell.

Don’t Miss: California Gas Prices: An Omen for the Entire U.S.?

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com